Digital Diagnostics Market Report 2026

The digital diagnostics market size has grown exponentially in recent years. It will grow from $2.15 billion in 2025 to $2.64 billion in 2026 at a compound annual growth rate (CAGR) of 22.5%. The growth in the historic period can be attributed to digitization of healthcare records, rising diagnostic test volumes, limitations of manual interpretation, growing chronic disease burden, increased imaging utilization.

The digital diagnostics market size is expected to see exponential growth in the next few years. It will grow to $5.83 billion in 2030 at a compound annual growth rate (CAGR) of 21.9%. The growth in the forecast period can be attributed to advancements in ai algorithms, expansion of telehealth diagnostics, demand for early disease detection, cloud-based diagnostics adoption, interoperability standards growth. Major trends in the forecast period include growing adoption of AI-enabled diagnostic tools, expansion of remote and point-of-care diagnostics, increased use of real-time health data analytics, integration of diagnostics with ehr systems, rising demand for predictive and preventive diagnostics.

The growing number of chronic illness cases is expected to drive the growth of the digital diagnostics market in the coming years. Chronic illnesses are long-term health conditions that require continuous monitoring and management, including cardiovascular diseases, diabetes, cancer, and chronic respiratory disorders. The incidence of these conditions is increasing due to aging populations and lifestyle-related factors such as poor dietary habits, lack of physical activity, tobacco consumption, and environmental influences. Digital diagnostics supports healthcare delivery by offering AI-enabled diagnostic tools, remote monitoring technologies, and digital health platforms that facilitate early diagnosis, ongoing monitoring, and personalized care for chronic diseases. For instance, in May 2023, according to the World Health Organization, a Switzerland-based global health body, chronic diseases such as cardiovascular conditions, cancer, diabetes, and respiratory illnesses are projected to account for around 86% of the estimated 90 million deaths annually by 2050. Therefore, the rising burden of chronic illnesses is driving the expansion of the digital diagnostics market.

Companies operating in the digital diagnostics market are increasingly focused on developing advanced technologies such as AI-driven digital cytology systems to improve diagnostic precision, optimize laboratory workflows, and enable remote analysis through advanced imaging solutions. Digital cytology systems use high-resolution imaging combined with artificial intelligence to analyze cytological samples, supporting faster and more accurate diagnoses. For instance, in February 2024, Hologic Inc., a US-based medical technology company, received approval from the U.S. Food and Drug Administration for its Genius Digital Diagnostics System integrated with the Genius Cervical AI algorithm. This system is the first FDA-cleared digital cytology platform that combines deep-learning AI with volumetric imaging to detect pre-cancerous lesions and cervical cancer cells. Unlike traditional Pap test evaluations that rely on manual microscopic examination, the system digitizes glass slides and uses AI to highlight clinically relevant cells for expert review.

In October 2023, Kingsway Financial Services, a US-based holding company, acquired Digital Diagnostics Imaging for $11 million. With this acquisition, Kingsway aims to strengthen its healthcare and telehealth portfolio by incorporating Digital Diagnostics Imaging’s remote cardiac monitoring services, enabling recurring revenue streams and broader market reach. Digital Diagnostics Imaging is a US-based provider of digital diagnostic systems and related services.

Major companies operating in the digital diagnostics market are Hoffmann-La Roche Holding AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers, Koninklijke Philips N.V., General Electric Company, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Hologic Inc., bioMérieux S.A., Bio-Rad Laboratories Inc., Fulgent Genetics Inc., Guardant Health Inc., Tempus Labs Inc., Genomic Health Inc., EDX Medical Inc., PathAI Inc., Healthy.io Ltd., BrightInsight Inc., Digital Diagnostics Inc., Brainomix Limited, DnaNudge Ltd., GRAIL Inc.

North America was the largest region in the digital diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the digital diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the digital diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the digital diagnostics market by increasing costs of imported diagnostic hardware, sensors, imaging components, and computing infrastructure. Hospitals and diagnostic laboratories in North America and Europe are most affected due to dependence on imported high-end equipment, while Asia-Pacific faces elevated setup costs for digital platforms. These tariffs raise deployment expenses. However, they also encourage domestic manufacturing of diagnostic hardware and regional software innovation.

The digital diagnostics market research report is one of a series of new reports that provides digital diagnostics market statistics, including digital diagnostics industry global market size, regional shares, competitors with a digital diagnostics market share, detailed digital diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the digital diagnostics industry. This digital diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Digital diagnostics involves the application of advanced digital technologies such as artificial intelligence, machine learning, data analytics, and imaging systems to detect, monitor, and predict health conditions with high accuracy and efficiency. By leveraging electronic health records, wearable devices, and digital diagnostic tools, these solutions enable real-time data collection, analysis, and interpretation, supporting healthcare professionals in making informed and precise clinical decisions.

The main product categories in the digital diagnostics market include hardware, software, and services. Hardware refers to the physical devices used to perform diagnostic tests and collect health data. Digital diagnostics solutions are applied across areas such as cardiology, gynecology, infectious diseases, oncology, diabetes, and others, and are utilized by end users including hospitals and clinics, clinical laboratories, pharmaceutical and biotechnology companies, academic and research institutes, and other healthcare organizations.

The digital diagnostics market consists of revenues earned by entities by providing services such as remote patient monitoring, digital imaging analysis, telehealth diagnostics, and genomic and biomarker analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. The digital diagnostics market also includes sales of digital X-ray systems, point-of-care testing devices, pathology slide scanners, and genetic testing kits. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.